Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Promising activity reported for Nipent combination therapy in NHL

July 14, 2003

New antiproliferative agents in Sankyo development pipeline

July 14, 2003

Cytotoxic macrolactones discovered at GBF assumed to act by inhibiting V-ATPase

July 14, 2003

New telomerase inhibitors under study at Kyowa Hakko

July 14, 2003

Reduced toxicity and improved antitumor effects for IL-2 when coadministered with M-40403

July 14, 2003

Potential new molecularly targeted therapies for diseases related to activated PDGFR-alpha

July 14, 2003

Beneficial effects described for bortezomib in patients with relapsed, refractory myeloma

July 14, 2003

Clinical efficacy of tetrathiomolybdate in advanced kidney cancer

July 11, 2003

FibroGen awarded grant to develop cancer therapies

July 11, 2003

Preliminary findings reveal troponin I suppresses genes associated with angiogenesis

July 11, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...